Pediatric cancer relapse prediction is an essential area of research, especially for conditions like glioma, which impact many young lives.Recent advances in AI in pediatric oncology have transformed how we approach brain tumor monitoring, allowing clinicians to foresee potential recurrence more accurately than ever before.